Condition: Radiotherapy Side Effect · Vaginal Abnormality · Sponsor: Jessa Hospital
This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
This description comes directly from the study's public registry record.
Jeroen Mebis, Prof. Dr. · +32 11 33 72 21 · jeroen.mebis@jessazh.be
Marithé Claes, MSc · +32 11 33 72 39 · marithe.claes@uhasselt.be
Always discuss trial participation with your own doctor first.
| Ziekenhuis Oost-Limburg | Genk, Limburg, Belgium | Recruiting |
| Jessa Hospital | Hasselt, Limburg, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05165056